Search results for "acetaldehyde"

showing 10 items of 90 documents

P-77D-PENICILLAMINE, A POTENTIAL ETHANOL ANTI-RELAPSE DRUG, DOES NOT REDUCE THE VOLUNTARY ETHANOL INTAKE IN LONG-TERM EXPERIENCED RATS

2015

Experimental evidence has demonstrated that the reinforcing effects of ethanol crucially depend on the brain formation of acetaldehyde (ACD). Rationally supported by this basis, we previously evaluated a novel strategy to prevent relapse in alcoholism based on chemical ACD inactivation using D-Penicillamine (DP). Under our experimental …

DrugEthanolbusiness.industrymedia_common.quotation_subjectPenicillamineAcetaldehydeGeneral MedicinePharmacologychemistry.chemical_compoundchemistryBiochemistrymedicineEthanol intakebusinessmedicine.drugmedia_commonAlcohol and Alcoholism
researchProduct

Pre-Clinical Studies with D-Penicillamine as a Novel Pharmacological Strategy to Treat Alcoholism: Updated Evidences

2017

Ethanol, as other drugs of abuse, is able to activate the ventral tegmental area dopamine (VTA-DA) neurons leading to positively motivational alcohol-seeking behavior and use, and, ultimately to ethanol addiction. In the last decades, the involvement of brain-derived acetaldehyde (ACD) in the ethanol actions in the mesolimbic pathway has been widely demonstrated. Consistent published results have provided a mechanistic support to the use of ACD inactivating agents to block the motivational and reinforcing properties of ethanol. Hence, in the last years, several pre-clinical studies have been performed in order to analyze the effects of the sequestering ACD agents in the prevention of ethano…

Drugmedia_common.quotation_subjectMini ReviewCognitive NeurosciencePsychological interventionMesolimbic pathwayPharmacologyBioinformaticsRelapse preventionethanol relapse prevention03 medical and health sciencesBehavioral Neuroscience0302 clinical medicineDopamineIntervention (counseling)acetaldehyde sequestering agentMedicinevoluntary alcohol consumptionpre-clinical studiesmedia_commonbusiness.industryAddictionD-penicillamine030227 psychiatryVentral tegmental areamedicine.anatomical_structureNeuropsychology and Physiological Psychologybusiness030217 neurology & neurosurgerymedicine.drugNeuroscienceFrontiers in Behavioral Neuroscience
researchProduct

Oxide anodes in electro-organic oxidation. Oxidation of maleic addon tungsten oxide anodes

1982

The electrochemical oxidation of maleic acid on tungsten anodes has been investigated. Glyoxal and carbon dioxide were the main products together with tartaric acid and acetaldehyde. Glyoxal is also obtained as the main product from the oxidation ofd-tartaric acid. Under the same conditions succinic acid is completely oxidized to carbon dioxide and water. The anodic dissolution of tungsten and the oxidation of water to oxygen become predominant in the final stages of the electrolyses.

Electrolysis of waterMaleic acidChemistryGeneral Chemical EngineeringInorganic chemistryOxideAcetaldehydechemistry.chemical_elementTungstenequipment and supplieschemistry.chemical_compoundSuccinic acidMaterials ChemistryElectrochemistryTartaric acidGlyoxalJournal of Applied Electrochemistry
researchProduct

P-76D-PENICILLAMINE, AN ACETALDEHYDE SEQUESTERING AGENT, REDUCES ETHANOL PREFERENCE IN ALCOHOL-NAÏVE RATS

2015

In previous investigations, we demonstrated that D-penicillamine (DP), a sulfhydryl aminoacid which has been studied as sequestration agent of acetaldehyde (ACD), is able to prevent the alcohol deprivation effect (ADE) but not voluntary ethanol consumption. Both results were obtained in long-term ethanol-experienced Wistar rats. Based on a previous …

Ethanol preferencechemistry.chemical_compoundEthanolBiochemistryChemistryPenicillaminemedicineAcetaldehydeAlcoholSequestering AgentGeneral MedicinePharmacologymedicine.drugAlcohol and Alcoholism
researchProduct

Ethanol releases corticotropic releasing hormone (CRH) from rat hypothalamic explants; role of acetaldehyde

2009

Ethanol activates hypothalamic-pituitary-adrenal (HPA) axis, resulting in adrenocorticotropic hormone (ACTH) glucocorticoid release, and a modification of the response of this axis to other stressors (Lee et al 1999, 2000). To determine the mechanisms responsible for these effects we investigated : 1) whether ethanol was able to release CRH from incubated hypothalamic explants; 2) whether acetaldehyde (ACD), its first metabolite formed in the brain by catalase activity, might play a role in ethanol effects. To this aim, rat hypothalamic explants were incubated with: 1) medium containing ethanol at 150 mg %; 2) different concentrations of ACD (4.4, 13.2, 44, 132 x 10-3 mg%); 3) ethanol plus …

Ethanol CRH Hypotalamus AcetaldehydeSettore BIO/14 - Farmacologia
researchProduct

Ethanol stimulates corticotropic releasing hormone (CRH) release from rat hypothalamic explants; role of acetaldehyde

2009

Ethanol is able to activate the hypothalamic-pituitary-adrenal (HPA) axis, and to modify its response to other stressors, releasing adrenocorticotropic hormone (ACTH), and glucocorticoid release, (Lee et al 1999, 2000). In the brain ethanol is diverted by catalase activity into acetaldehyde, which is reported to mediate some of its behavioural and neurochemical effects. (Peana et al 2008, Melis et al 2007) Thus, to clarifìy the mechanisms underlying ethanol activity on the HPA axis we investigated :1) ethanol effect on CRH release from incubated hypothalamic explants; 2) the role of acetaldehyde (ACD), in mediating ethanol activity. To this aim, rat hypothalamic explants were incubated with…

EthanolCRHSettore BIO/14 - FarmacologiaHypotalamuacetaldehyde
researchProduct

SY26-2ACETALDEHYDE ENDOCANNABINOIDS AND DOPAMINE: IS THIS –JUST- “A MENAGE A TROIS”?

2015

As ethanol, its first metabolite, acetaldehyde (ACD), enhances dopamine neurotransmission and exerts rewarding and motivational effects in animal models tailored for studying addictive-like behaviours. The endocannabinoid system fine-tuning dopamine cell activity, affects distinct drug-related behaviours and specific drug-induced effects. In light of this, it becomes urgent to investigate the implications of …

EthanolDopamine neurotransmissionMetaboliteAcetaldehydeendocannabinoidGeneral MedicinePharmacologyBiologyEndocannabinoid systemCell activitychemistry.chemical_compoundchemistryDopamineSettore BIO/14 - FarmacologiamedicinedopamineNeuroscienceacetaldehydemedicine.drugAlcohol and Alcoholism
researchProduct

Acetaldehyde and salsolinol in ethanol’s two-step mechanism of action: An overview

2018

In the last years, numerous studies have supported the idea that, at least in part, motivational and neuropharmacological effects of ethanol are mediated by its first brain-derived metabolite, acetaldehyde, and its bioderivate salsolinol. This review aims at gathering and shaping as a whole the evidence on their role in the mechanism of action of ethanol. Acetaldehyde and salsolinol interact with the reward brain system and are involved as primum movens of motivational and addictive behaviour that can be especially relevant to ethanol use disorders. Understanding the neurobiology of acetaldehyde and salsolinol holds promising potential for the development of novel pharmacological approaches…

EthanolEthanolBiochemistry (medical)Two stepAcetaldehydeAcetaldehydePlant ScienceCombinatorial chemistryGeneral Biochemistry Genetics and Molecular BiologySalsolinolchemistry.chemical_compoundethanol acetaldehyde salsolinol rewardRewardchemistryMechanism of actionlcsh:Biology (General)medicinemedicine.symptomlcsh:QH301-705.5Journal of Biological Research
researchProduct

Effect of Acetaldehyde on CRF release form incubated hypothalamic explants

2008

In the past, Acetaldehyde (ACD), the main metabolite of ethanol (ETOH), was mainly studied for its toxic and adverse effects (1). However, recently, ACD was reported to determine behavioural and neurochemical effects, following ETOH assumption in rodents (2, 3). Indeed, ACD enhances dopamine levels in nucleus accumbens, stimulates beta-endorphin release from hypothalamic cells, mediating alcohol reinforcing effects (4). Since little is known about the effects of ACD on other central neuropeptides, in this research we aimed to investigate ACD influence on hypothalamic corticotropin-releasing factor (CRF) release. In order to ascertain this hypothesis, different doses of ACD (1, 10, 3x10 micr…

EthanolSettore BIO/14 - FarmacologiaAcetaldehydeHypotalamic CRF release
researchProduct

Sucrose medium osmolality as a regulator of anabolic and catabolic parameters inZymomonas culture

1996

This study focuses on the growth of Zymomonas mobilis strain 113 S and its ethanol and levan production under the conditions of increasing sucrose medium osmolality caused by NaCl, KCl, sorbitol or maltose. The increase in medium osmolality (700-1,500 mosml/kg) was accompanied by the inhibition of growth (growth rate, biomass yield) and ethanol production (specific productivity and yield). In contrast, levan synthesis was less affected or even stimulated and, as a consequence, levan specific productivity was increased significantly. A decrease in the anabolic growth parameters correlated with a parallel inhibition of glucose-6-P dehydrogenase and alcohol dehydrogenase (isoenzyme ADH II) act…

EthanolbiologyAcetaldehydeBioengineeringbiology.organism_classificationApplied Microbiology and BiotechnologyZymomonas mobilischemistry.chemical_compoundchemistryBiochemistrybiology.proteinEthanol fuelFermentationSorbitolPyruvate decarboxylaseBiotechnologyAlcohol dehydrogenaseActa Biotechnologica
researchProduct